Chemotherapeutic regimens for early high risk ovarian cancer

被引:1
|
作者
Geisler, I. [1 ]
Labarge, D. [1 ]
Phibbs, G. [1 ]
Manahan, K. [1 ]
机构
[1] Univ Toledo, Med Ctr, Toledo, OH 43606 USA
关键词
D O I
10.1016/j.ygyno.2011.12.216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
215
引用
收藏
页码:S89 / S89
页数:1
相关论文
共 50 条
  • [21] Counseling patients with recurrent/progressive epithelial ovarian cancer: What is the true efficacy of advanced-line chemotherapeutic regimens?
    King, E. R.
    Jazaeri, A. A.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S64 - S64
  • [22] Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer
    Lux, MP
    Ackermann, S
    Nestle-Krämling, C
    Goecke, TO
    Niederacher, D
    Bodden-Heidrich, R
    Bender, HG
    Beckmann, MW
    Fasching, PA
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (04) : 399 - 411
  • [23] High risk breast/ovarian cancer families:: Genetic counselling, testing and early cancer detection program
    Beckmann, MW
    Niederacher, D
    Cho, JY
    An, HX
    Kuschel, B
    Achnoula, M
    Goecke, TO
    Bodden-Heidrich, R
    Schnürch, HG
    Bender, HG
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S16 - S17
  • [24] Early cancer detection programmes for women at high risk for breast and ovarian cancer: A proposal of practical guidelines
    Beckmann, MW
    Schnurch, HG
    BoddenHeidrich, R
    Mosny, DS
    Crombach, G
    Nitz, U
    Achnoula, M
    Bender, HG
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 (06) : 468 - 475
  • [25] Outlook for recent chemotherapeutic agents in ovarian cancer
    Mobus, V
    Volm, T
    Kreienberg, R
    GYNAKOLOGE, 1997, 30 (02): : 108 - 117
  • [26] Novel chemotherapeutic approach for treating ovarian cancer
    Askeland, Georgina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (04) : 353 - 353
  • [27] High-risk epithelial ovarian cancer patients for hereditary ovarian cancer
    Chirasophon, Seksit
    Manchana, Tarinee
    Teerapakpinyo, Chinachote
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (05) : 929 - 934
  • [28] VERTEPORFIN, A NEW CHEMOTHERAPEUTIC OPTION IN OVARIAN CANCER
    Dasari, V.
    Smith, A.
    Gogoi, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 520 - 520
  • [29] UPDATES ON EARLY DETECTION AND RISK STRATIFICATION FOR OVARIAN CANCER
    Bast, R.
    TUMOR BIOLOGY, 2010, 31 : S122 - S123
  • [30] Identifying women at high risk of ovarian cancer
    Sweet, Jim
    Edwards, Paul
    Gartner, Daniel
    Threlfall, John
    Redmond, Nell
    Edwards, Shannon
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2022, 22